CJC-1295 vs Sermorelin: Which GH Peptide Should You Choose?

CJC-1295 and Sermorelin both stimulate growth hormone release via the GHRH pathway, but they differ significantly in half-life, dosing frequency, and how closely they mimic natural GH patterns. Here is how they compare.

CJC-1295

Sermorelin

Mechanism

Modified GHRH analogue (29 amino acids + modifications). Binds GHRH receptors on pituitary.

Synthetic GHRH 1-29 (first 29 amino acids of natural GHRH). Identical target but unmodified.

Half-Life

Without DAC: ~30 minutes. With DAC: ~8 days. Modified structure resists enzymatic degradation.

~10-20 minutes. Rapidly degraded by DPP-IV enzyme. Requires more frequent dosing.

GH Release Pattern

Without DAC: pulsatile (natural). With DAC: sustained elevation (less physiological).

Short, pulsatile release that closely mimics natural GH secretion pattern.

Dosing

No DAC: 100-300mcg 1-3x daily. With DAC: 2mg 1-2x weekly.

200-300mcg before bed daily. Sometimes 100mcg 2x daily.

Clinical History

Studied in clinical trials but never FDA-approved. Well-researched pharmacokinetics.

Previously FDA-approved as Geref Diagnostic. Longer clinical track record.

Price Range

$30-$60 per 5mg vial.

$25-$50 per 5mg vial. Slightly more affordable.

The Verdict

Sermorelin is the more conservative choice with a longer safety track record and more natural GH pulsatile release. CJC-1295 (without DAC) offers similar pulsatile release with a longer half-life, requiring less frequent dosing. CJC-1295 with DAC provides sustained GH elevation but is less physiological. For researchers seeking natural GH patterns: Sermorelin or CJC-1295 no DAC. For convenience: CJC-1295 with DAC.

Frequently Asked Questions

Is CJC-1295 stronger than sermorelin?

CJC-1295 has a longer half-life and may produce more sustained GH elevation, especially the DAC version. However, 'stronger' depends on goals. Sermorelin produces more natural GH pulses. Both effectively increase GH levels.

Can you combine CJC-1295 with sermorelin?

This is uncommon since both target the same GHRH receptor. More common combinations pair either CJC-1295 or sermorelin with a GHRP (like Ipamorelin or GHRP-2) for synergistic GH release through complementary pathways.

Which has fewer side effects?

Both have similar and generally mild side effect profiles: flushing, headache, dizziness, injection site reactions. Sermorelin's shorter half-life means any side effects resolve faster. CJC-1295 with DAC may cause more prolonged side effects.

Research & Education Only — The information on this page is for research and educational purposes only. It does not constitute medical advice. Consult a qualified healthcare professional before making any decisions.